Small Impact Factor

Source limitations: public pages do not expose every paid JCR field. The exact category rank should be verified inside JCR before a formal bibliometrics statement. For manuscript targeting, the current JIF, Q1 status, ISSNs, trend, and comparator position are enough to decide whether Small belongs on the shortlist.

Manusights internal analysis identifies the page's practical edge as the source contradiction plus the manuscript-fit bridge: 11.8 is the current two-year JIF, 12.1 is still useful but belongs to five-year or prior-year context, and neither number replaces the Small-specific evidence-package decision.

An 11.8 JIF tells you that Small remains a strong nanoscience and applied-materials journal, but it does not mean every nano-labeled manuscript belongs there. Small sits below flagship materials outlets such as Advanced Materials, Advanced Functional Materials, and ACS Nano by current JIF, while still sitting above many specialty nanoscience and applied-materials alternatives.

The more useful interpretation is the gap between the two-year and five-year values. Small's current JIF is 11.8 and its five-year JIF is 12.1. That narrow difference suggests the journal's citation base is stable rather than being driven only by a short spike. The year-over-year decline from 12.1 to 11.8 is real, but it is small enough that it should change manuscript fit less than scope, evidence package, and audience.

For authors, 11.8 is a fit filter, not a prestige guarantee. Small works best when the nano or micro-scale contribution is central, experimentally supported from structure through function, and broad enough for readers outside one application niche. If the paper is mainly one performance benchmark, one device optimization, or one characterization method with a large claim attached, the JIF can overstate the editorial fit.

The trend says the journal is no longer at its 2021 peak, but the current value is not a collapse. It is closer to the pre-surge 2019-2020 band than to a weaker field position. For a submission decision, that means you should not chase or avoid Small because of a 0.3 year-over-year change. You should ask whether the paper reads like a complete nanoscience contribution.

Small's rank story is multi-category. The journal is listed across chemistry, materials science, nanoscience and nanotechnology, applied physics, and condensed matter physics. That helps reach, but it also means authors compete against papers with very different evidence standards. A polymer nanocomposite, a bio-nano therapeutic system, and a nanoelectronics device can all fit the scope while needing different proof packages.

Small publishes across nano and micro-scale research, so the evidence package has to make the scale matter. A manuscript should not merely use nanoparticles, nanofibers, nanosheets, or microstructures as decoration. It should show that the nanoscale design changes mechanism, performance, delivery, stability, interface behavior, or device operation.

In our review work on Small submissions and nearby nanoscience targets, we see five recurring patterns that decide whether the 11.8 metric is a good fit signal or a misleading prestige shortcut. These are not official Wiley rules. They are Manusights submission analysis patterns drawn from how Small-like manuscripts read before upload: claims, figures, methods, controls, benchmarks, and scope framing.

Small characterization-only nano paper. A synthesis plus size distribution, microscopy figures, zeta potential, and routine spectroscopy is usually not enough if the claim is about energy storage, sensing, catalysis, therapy, or device behavior. The application claim needs a matched functional test and a credible benchmark.

Small application claim without the right comparator. A battery, sensor, photothermal, antimicrobial, or drug-delivery claim needs comparison against a relevant material, device, or biological baseline. "Better than our control" is weaker than "better than the field's plausible alternative under comparable conditions."

Small versus ACS Nano or Advanced Functional Materials overreach. Some papers are strong enough for Small but not strong enough for ACS Nano or Advanced Functional Materials. That is not a downgrade if the evidence package is complete and the audience is the broad nano community. The specific failure pattern is pretending a good Small paper has flagship breadth when the figures mainly support a narrower nano-mechanism.

Small versus Nano Letters short-result mismatch. If the paper is one elegant mechanism or one compact discovery, Nano Letters may fit better than Small. If the paper needs multiple figures to prove synthesis, structure, methods, mechanism, and function, Small is usually the more natural lane.

Small bio-nano translational evidence mismatch. Bio-nano papers often fail the fit test when they make therapeutic, diagnostic, or toxicity claims without the sample, control, toxicity, or biological mechanism evidence expected by the claim. Small can publish bio-nano work, but the biology cannot be a thin add-on.

This is the editorial triage pattern behind the metric page: Small is a good target when the manuscript's methods and figures make the nano-scale contribution convincing across synthesis, structure, mechanism, and function. It is a weak target when the number 11.8 is doing more persuasive work than the evidence package.

A Small journal-fit check can test whether your evidence package reads as a complete Small submission or whether ACS Nano, Nano Letters, Nanoscale, or a narrower applied journal is a cleaner target.

If Small stays on the shortlist after the metric check, a Small pre-submission readiness check can review the figures, methods, benchmarks, and scope argument before upload.

The JIF does not tell you whether the editor will see the nano contribution as central. It also does not tell you whether your article type, figure package, cover letter, or scope statement is strong enough for review. A high JIF page can answer "how cited is this journal?" but it cannot decide whether your manuscript has the right evidence for Small.

Use the 11.8 JIF as one input beside:

• the journal's exact title and ISSN match
• whether the paper is broad nanoscience rather than narrow application work
• whether the evidence package supports the claim scale
• whether the comparison set includes the right nearby journals
• whether timing, APC, and formatting constraints are acceptable

For adjacent planning, use the Small journal hub, Small APC and open access guide, Small acceptance-rate guide, and Small formatting requirements. If the real choice is between formats, see the Small vs Nano Letters comparison.